Propel Health Appoints Veteran Communications Executive Jeff Keller as President of Medical Affairs Business Unit, Signaling Strategic Expansion in Life Sciences Engagement
Propel Health, a premier provider of strategic communications and engagement solutions for the life sciences industry, has announced the appointment of Jeff Keller as President of its Medical Affairs business unit. This strategic leadership move reinforces the company’s commitment to deepening its capabilities in medical affairs, scientific communications, and integrated engagement, as it continues to evolve as a go-to partner for pharmaceutical and biotechnology companies navigating the complex landscape of scientific engagement.
Jeff Keller, a widely respected figure in healthcare communications, brings more than 30 years of industry experience to his new role. Throughout his career, Keller has built a reputation for operational excellence, organizational leadership, and a forward-thinking approach to medical strategy. In his new position, he will spearhead Propel Health’s expansion of medical affairs offerings and will be responsible for guiding strategy, scaling capabilities, and delivering innovative, client-centric solutions that support the company’s continued growth.
A Track Record of Strategic Growth and Innovation
Prior to joining Propel Health, Keller most recently served as President of Citrus Scientific, where he led the successful integration of four acquired companies. Under his leadership, Citrus saw robust growth, driven by the introduction of strategic initiatives that fostered both organic development and the acquisition of new business. During his tenure, Keller oversaw impactful scientific communication programs in high-growth therapeutic areas such as gene therapy, oncology, and neuroscience—sectors that are rapidly shaping the future of medicine and where Keller’s expertise is expected to have immediate influence at Propel Health.
Earlier in his career, Keller held senior executive roles at some of the most recognized names in medical communications, including The Curry Rockefeller Group, ICON plc, and Complete Healthcare Communications (CHC), a division of MediMedia. His leadership across these organizations contributed to the development and scaling of high-performing teams, the cultivation of long-term client relationships, and the delivery of scientifically rigorous and compliant communication strategies in support of drug development and commercialization efforts.
A Strategic Appointment Aligned with Propel Health’s Vision
The appointment of Jeff Keller comes at a key inflection point for Propel Health as the company doubles down on expanding its medical affairs capabilities to meet rising industry demand for credible, science-driven engagement with healthcare professionals, regulatory bodies, and patient communities.
“We are thrilled to welcome Jeff Keller to Propel Health,” said Mark Fleischer, CEO of Propel Health. “Jeff brings a rare combination of strategic acumen, deep industry knowledge, and a hands-on leadership style that we believe will be instrumental in taking our Medical Affairs business unit to the next level. His extensive experience scaling teams, fostering innovation, and delivering client value positions him as the ideal leader for this next phase of growth.”
Fleischer emphasized that as the pharmaceutical and biotechnology industries face increased pressure to demonstrate value and scientific integrity in a competitive landscape, Propel Health’s ability to offer sophisticated, integrated engagement strategies has never been more critical.
“Medical affairs is playing an increasingly central role in shaping the success of life sciences companies—from early-stage evidence generation through launch and lifecycle management,” Fleischer added. “Jeff’s appointment strengthens our ability to serve as a strategic partner across that entire continuum.”
Embracing a Mission-Driven Opportunity
In his first public remarks since the announcement, Keller expressed enthusiasm about the opportunity to join a company whose mission and values closely align with his own.
“I’m excited to join Propel Health at such a pivotal time for the company and for the industry at large,” Keller said. “Propel’s unwavering commitment to scientific excellence, innovation, and partnership resonates deeply with my own passion for medical affairs and scientific storytelling. I look forward to collaborating with the outstanding team at Propel to build on this momentum and continue delivering impactful solutions that benefit our clients, healthcare professionals, and ultimately, patients worldwide.”
Keller’s appointment reflects a broader industry trend of elevating medical affairs into a more strategic and central function within life sciences organizations. As biopharmaceutical companies increasingly rely on scientifically credible and compliant communications to inform and influence key stakeholders, the need for experienced leadership in this space becomes paramount.
A Career Built on Science and Service
Jeff Keller holds a Bachelor of Science in Business Administration from the University of Denver, a foundation that has supported his unique blend of business strategy and scientific insight throughout his career. His approach combines commercial awareness with a deep understanding of the regulatory and clinical complexities that define the life sciences sector.
His leadership style is characterized by a focus on empowering cross-functional teams, fostering client trust through transparent collaboration, and maintaining a laser focus on delivering high-quality, evidence-based solutions that support better healthcare outcomes.
As Propel Health continues to invest in its capabilities and expand its global footprint, the addition of Jeff Keller signals a renewed focus on building industry-leading medical affairs services tailored to the evolving needs of the life sciences sector. His appointment is expected to accelerate Propel’s trajectory as a preferred partner for pharmaceutical and biotech companies seeking scientific rigor, strategic clarity, and meaningful engagement in a rapidly changing healthcare environment.
With Keller at the helm of its Medical Affairs business unit, Propel Health is poised to meet the increasing demand for integrated, impactful medical communications solutions that help life sciences companies succeed in their missions to improve human health.
